These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22892087)

  • 1. [Value of sputum analysis in the management of inflammatory airway diseases].
    Mazzei JA; Rocher AE; Palaoro L
    Medicina (B Aires); 2012; 72(4):332-8. PubMed ID: 22892087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced sputum, eosinophilic bronchitis, and chronic obstructive pulmonary disease.
    Hargreave FE; Leigh R
    Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 2):S53-7. PubMed ID: 10556171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the inflammatory component of airway diseases by induced sputum cell counts: use in clinical practice.
    Moritz P; Steidle LJ; Felisbino MB; Kleveston T; Pizzichini MM; Pizzichini E
    J Bras Pneumol; 2008 Nov; 34(11):913-21. PubMed ID: 19099097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical application of induced and spontaneous sputum in asthma and chronic obstructive pulmonary disease].
    Antus B
    Orv Hetil; 2012 Nov; 153(47):1847-54. PubMed ID: 23160075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Control of asthma symptoms and cellular markers of inflammation in induced sputum in children and adolescents with chronic asthma].
    Ciółkowski J; Stasiowska B; Mazurek H
    Pol Merkur Lekarski; 2009 Mar; 26(153):178-83. PubMed ID: 19388528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of sputum differential count in chronic obstructive airway disease.
    Neopane A; Sharma L; Dulal S; Panta S
    J Nepal Health Res Counc; 2013 Jan; 11(23):26-9. PubMed ID: 23787521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical applications of induced sputum.
    Brightling CE
    Chest; 2006 May; 129(5):1344-8. PubMed ID: 16685028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
    Siva R; Green RH; Brightling CE; Shelley M; Hargadon B; McKenna S; Monteiro W; Berry M; Parker D; Wardlaw AJ; Pavord ID
    Eur Respir J; 2007 May; 29(5):906-13. PubMed ID: 17301099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of inflammation and the use of reversibility testing in smokers with airway complaints.
    Chavannes NH; Vernooy JH; Schermer TR; Jacobs JA; Dentener MA; van Weel C; van Schayck OC; Wouters EF
    BMC Pulm Med; 2006 Jun; 6():11. PubMed ID: 16740168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathogenesis and clinical features of nonasthmatic eosinophilic bronchitis].
    Dor-Wojnarowska A; Panaszek B
    Pneumonol Alergol Pol; 2007; 75(4):389-93. PubMed ID: 18080990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of induced sputum examination in respiratory system diseases].
    Bareła-Malczewska AD; Chazan R
    Pol Merkur Lekarski; 2011 Feb; 30(176):126-31. PubMed ID: 21544983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sputum induction and its application in assessing airway inflammation].
    Liu YH; Dong JC
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 May; 27(5):336-9. PubMed ID: 15196346
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative sputum cell counts as a marker of airway inflammation in clinical practice.
    Hargreave FE
    Curr Opin Allergy Clin Immunol; 2007 Feb; 7(1):102-6. PubMed ID: 17218819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of induced sputum in the diagnostics of selected chronic inflammatory airway diseases].
    Sozańska E; Barczyk A; Biedroń-Machura M; Pierzchała W
    Pneumonol Alergol Pol; 2009; 77(4):349-56. PubMed ID: 19722139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma, COPD and bronchitis are just components of airway disease.
    Hargreave FE; Parameswaran K
    Eur Respir J; 2006 Aug; 28(2):264-7. PubMed ID: 16880365
    [No Abstract]   [Full Text] [Related]  

  • 16. Induced sputum in the management of COPD: clinical implications.
    Zanini A; Della Patrona S; Facchini AL; Spanevello A
    Monaldi Arch Chest Dis; 2012 Mar; 77(1):23-5. PubMed ID: 22662642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of irreversible airflow obstruction in a patient with eosinophilic bronchitis without asthma.
    Brightling CE; Woltmann G; Wardlaw AJ; Pavord ID
    Eur Respir J; 1999 Nov; 14(5):1228-30. PubMed ID: 10596716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eosinophilic bronchitis: clinical manifestations and implications for treatment.
    Gibson PG; Fujimura M; Niimi A
    Thorax; 2002 Feb; 57(2):178-82. PubMed ID: 11828051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic bronchitis sub-phenotype within COPD: inflammation in sputum and biopsies.
    Snoeck-Stroband JB; Lapperre TS; Gosman MM; Boezen HM; Timens W; ten Hacken NH; Sont JK; Sterk PJ; Hiemstra PS;
    Eur Respir J; 2008 Jan; 31(1):70-7. PubMed ID: 17804442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced sputum for the investigation of airway inflammation: evidence for its clinical application.
    Hargreave FE
    Can Respir J; 1999; 6(2):169-74. PubMed ID: 10322099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.